All Access Articles |
- FDA Approves Novavax's Nuvaxovid™ for High-Risk Groups | 2025-08-28 | BIOTECHNOLOGY
- Novavax Refinances Convertible Debt | 2025-08-21 | BIOTECHNOLOGY
- Novavax's COVID-Influenza Vaccine Shows Strong Immune Response | 2025-06-11 | BIOTECHNOLOGY